NCT07203053
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07203053
Title A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2 (START-lung)
Acronym START-lung
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ETOP IBCSG Partners Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | GRC | FRA | ESP | CHE


No variant requirements are available.